FDA NDC Directory · JSON-LD · Markdown

Potassium Citrate

NDC 65841-538 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA203546
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsPOTASSIUM CITRATE (15 meq/1)
Marketing started20140812
Package count6

External sources

Source: openFDA. Public-domain (CC0).